Picture of BrightPath Biotherapeutics Co logo

4594 BrightPath Biotherapeutics Co News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Table: Green Peptide -6-MTH parent results

Nov 13 (Reuters)-  
             Green Peptide Co., Ltd.  
             PARENT-ONLY FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                 6 months ended      6 months ended        Year to   
                Sep 30, 2015        Sep 30, 2014      Mar 31, 2016   
                   LATEST             YEAR-AGO           LATEST      
                   RESULTS             RESULTS          FORECAST     
  Sales            415 mln                               832 mln     
                                                       (+1.3 pct)    
  Operating     loss 606 mln                            loss 1.34    
  Recurring     loss 593 mln                            loss 1.33    
  Net           loss 594 mln                            loss 1.33    
  EPS          loss 23.50 yen                        loss 47.15 yen  
  Ann Div                                NIL               NIL       
  -Q2 div            NIL                 NIL                         
  -Q4 div                                NIL               NIL       
   
  NOTE - Green Peptide Co., Ltd..  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4594.T  
  ((Tokyo Headline News Desk +813 6441 1812))

Recent news on BrightPath Biotherapeutics Co

See all news